Spain – Disposable non-chemical medical consumables and haematological consumables – Material desechable para cirugía endoscópica y laparoscópica

Spain – Medical consumables – Suministro de equipos de cobertura quirúrgica desechable, material auxiliar y elementos fungibles asociados para la Osi Bilbao Basurto, y puesta a disposición de un modelo de gestión logística automat

Spain – Social work services with accommodation – Atención residencial con atención diurna para personas adultas con discapacidad intelectual en proceso de envejecimiento prematuro

Spain – Medical consumables – Contratación del suministro de cobertura quirúrgica de un solo uso, en régimen de depósito, y su gestión, distribución, almacenamiento y reposición, para el Bloque Quirúrgico del Hospital Comarcal d'Amposta, S.A.M.

Expected Impact: The action under this topic is expected to achieve the following impacts: Accelerate EU access to more cost-effective interventions in an increasingly ageing population by identifying personalised treatment approaches for elderly-onset immune diseases. Decrease disease risk later in life by defining specific prevention strategies based on ageing biomarkers and risk factors. Halt age-associated disease exacerbation by the identification of predictive and digital biomarkers that can stratify patients for early intervention. Improve quality of life for healthy individuals and patients by preventing further health decline, avoiding escalating care costs, and properly stratifying individuals earlier in the diagnostic pathway. Accelerate adoption of innovative diagnostic, preventative, and therapeutic strategies, strengthening the EU’s position as a healthcare innovator. Evaluate digital biomarker as potential regulatory endpoints in the ultimate goal to develop medicines for ‘healthy ageing’. Integrate fragmented research efforts by bringing together health industry sectors and stakeholders to develop clinical and multi-omics data integration capabilities. Enable new…

Expected Outcome: This action aims to establish European leadership in neutral-atom quantum simulation and digital quantum computing by delivering: Fully programmable industry-ready quantum simulators based on 10.000 neutral atoms in a scalable architecture, accessible via cloud platforms, and with the possibility of integrating them into high-performance computing environments. Fully programmable platform for neutral-atom quantum computing capable of both analogue quantum operations and gate-based computing with 1.000 physical qubits and a clear path to further scalability to 10.000 physical qubits. Coherence time of the order of hundreds of interaction times and infidelity of operations below 1%. Demonstration of quantum simulation and/or computing operating beyond classical computability, validated through benchmarking with classical methods. New real-world applications across science and industry (at least two) (e.g: in the energy and health sectors) The software stack for these applications, including enhanced software for verification, algorithm implementation, and user programming interfaces. Demonstration of the full quantum stack – including quantum control, electronic…

Expected Impact: The action under this topic is expected to achieve the following impacts and contribute to the following EU policies/initiatives: deliver innovative, early technology solutions that contribute to addressing strategic unmet public health needs across multiple therapy areas to improve prevention, early diagnosis, and treatment; leverage the unique network and scale of IHI JU members to create a pipeline to support innovative startups in the health industry, fully integrated into European initiatives in support of start-ups and entrepreneurship; drive early cross-sector health R&D and innovation to strengthen the European healthcare industry’s global competitiveness, contributing to the EU Industrial Strategy and Pharmaceutical Strategy objectives; create a sustainable network of European healthcare incubators to guide and support highly talented and innovative early-stage companies; harness digital health and data-sharing technologies (e.g., AI and big data) to enable interoperable health solutions, contributing to the European Health Data Space (EHDS) and improved evidence based care;- the action should generate a portfolio of early‑stage companies that have…

Expected Outcome: This action will advance Europe’s leadership in trapped-ion quantum computing by achieving the following key outcomes: Establishment of a full-stack ion-trap quantum computer aiming at more than 1.000 qubits, fully integrated into high-performance computing (HPC) systems, and accessible via the cloud. Demonstration of quantum advantage for selected real-world applications, validated against benchmarks. Strengthened European capabilities to develop modular, interoperable, and scalable quantum computing architectures. Implementation and demonstration of advanced error correction and fault-tolerant quantum computing techniques. Integration of full-stack hardware-software systems with standardised and certified interfaces. Engagement with industry and academia through open access to quantum computing resources and co-design of applications. Scope: The action should support the scale-up of European trapped-ion quantum computing platforms, aiming at technological maturity and usability for industrial and scientific applications. In particular, the action must address at least two major technical roadblocks defined in the Strategic Research and Industry Agenda (SRIA…

Expected Outcome: This action will consolidate Europe’s position in superconducting quantum computing through: Establishment of a full-stack superconducting quantum computer aiming at 1.000 physical qubits and QPU architecture based on chiplet technology. The system should feature a scalable and user-adjustable architecture, T1 coherence time above 100 us, gate fidelities (both one- and two-qubit gates, and read-out) of at least 99.9%, read-out speed below 300 ns, two-qubit gate speed below 20 ns. Demonstration of quantum advantage on selected industrial use cases, validated through benchmarking with best-in-class classical methods. Deployment of a cloud-accessible quantum system integrated with high-performance computing environments. Maturation of fault-tolerant quantum computing protocols, including effective quantum error correction and noise mitigation schemes. Delivery of a comprehensive, standardised software stack supporting system bring-up, calibration, control, benchmarking, and user access. Strengthened supply chains and industrial capacity in Europe for superconducting quantum technologies. Scope: The proposal should contribute to the scale-up and practical deployment…

Expected Outcome: This action will establish a strategic European initiative to develop scalable, modular, and interoperable photonic quantum computing platforms. Proposals for this topic are expected to address and provide credible solutions to at least two major technical roadblocks currently limiting the advancement of photonic quantum computing such as: The lack of deterministic, high-efficiency photonic entanglement and loss-tolerant architectures suitable for fault-tolerant scaling The absence of a standardised, integrated control stack combining photonic hardware, firmware, and system software with reliable benchmarking across platforms Project results are expected to contribute to the following expected outcomes: By 2028, demonstration of a photonic NISQ processor with ≥100 photonic qubits, integrating deterministic single-photon sources, low-loss waveguides, on-chip detectors, and a firmware stack (scheduler, controller, compiler), validated via hardware-agnostic benchmarks and hybrid photonic-HPC applications demonstrating classical-quantum crossover By 2030, delivery of a full-stack, high-connectivity photonic quantum computer, with modular scalability, integrated…

Expected Outcome: This action will strengthen Europe's strategic autonomy in quantum-secure communications by advancing core QKD technologies and integration capabilities. Expected results include: Development and demonstration of next-generation QKD systems, with a focus on cost-effectiveness and integration, with specific measurable improvements in one of the following parameters or features: (i) key rate (>1 Mbps over metropolitan distances), (ii) operational coverage of a network at the regional scale, >300 km for fibre-based QKD, including e.g. twin field and free-space links also for non-wired segments and for redundancy, (iii) development and demonstration of advanced quantum cryptographic protocols beyond QKD with provable security advantage over classical cryptographic systems. Implementation of hybrid quantum-classical cryptographic frameworks combining QKD and post-quantum cryptography (PQC), tested on clearly defined real-world applications. Integration of quantum communication components with network equipment and orchestration systems (e.g., software-defined networking). Validation of QKD-based security in high-priority use cases beyond EuroQCI infrastructure,…